Relief Therapeutics Holding AG (RLFTF)

[PennyWorld]

pegs, I have no crystal ball. But I was hoping that ACER would have been ready for it's June 5 PDUFA event, but they weren't. So that is pushed off to mid January 2023. If the FDA approves their drug then that would generate a revenue stream for RLFTF which should give the pps a small boost.

NASDAQ...I'm still convinced that RAM is doing the ADR so that he will have another mechanism to dilute (by selling ADRs). He must wait until Level 3 is reached though before he can dilute like that. The big question for me is..... what impact will diluting per ADR selling have on the underlying stock (RLFTF)? Just don't know. But if we are forced to convert our OTC shares to ADR, then it is a moot point. We will then be at the mercy of the NASDAQ market place with the ADRs. Even if there is no RAM driven ADR dilution, then IMO we will still need a positive stream of good news being PR'd to sustain the new higher (150x) pps on the NASDAQ. And RAM may surprise us with a 250x conversion.